Jian-qi Q. Lian
569 Xinsi Rd
Xi'an, China
Xi'an, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 38 publications
The multifaceted roles of interleukin-36 in liver diseases: from pathogenesis to therapeutic potential.
Journal: International immunopharmacology
Published: February 15, 2026
Chikusetsu saponin IVa mitigates septic cardiac injury by targeting DRP1 to suppress mitochondrial damage and NLRP3 inflammasome activation.
Journal: Life sciences
Published: February 04, 2026
Pegylated Interferon-α-Induced Functional Cure for Special Populations with Chronic Hepatitis B Virus Infection: Current Trends, Challenges and Prospection.
Journal: Drug design, development and therapy
Published: August 30, 2025
Development and validation of a risk stratification score for hemophagocytic syndrome in chronic active Epstein-Barr virus infection: A 10-year retrospective cohort study.
Journal: Journal of infection and public health
Published: August 23, 2025
Comparison of clinical efficacy and secondary infections between conventional-dose and high-dose glucocorticoid in hemorrhagic fever with renal syndrome: a dual-center retrospective cohort study.
Journal: BMC infectious diseases
Published: March 21, 2025
Bridging gaps from mathematical model to clinical application: precision management of severe fever with thrombocytopenia syndrome.
Journal: Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases
Published: February 27, 2025
Recurrence risk factors for chronic hepatitis B virus-infected patients who achieve functional cure with pegylated interferon-α-2b-based therapy: a multicenter pilot study.
Journal: Virology journal
Published: February 16, 2025
Efficacy and safety of GLS4 with entecavir vs entecavir alone in chronic hepatitis B patients: A multicenter clinical trial.
Journal: The Journal of infection
Published: November 10, 2024
Meplazumab, a CD147 antibody, for severe COVID-19: a double-blind, randomized, placebo-controlled, phase 3 clinical trial.
Journal: Signal transduction and targeted therapy
Published: November 01, 2024
Glutamine-glutamate centered metabolism as the potential therapeutic target against Japanese encephalitis virus-induced encephalitis.
Journal: Cell & bioscience
Published: August 01, 2024
Clinical Characteristics and Fatality Risk Factors for Patients with Listeria monocytogenes Infection: A 12-Year Hospital-Based Study in Xi'an, China.
Journal: Infectious diseases and therapy
Published: February 28, 2024
T-cell immunoglobulin and mucin 1 (TIM-1) mediates infection of Hantaan virus in Jurkat T cells.
Journal: Virus research
Published: January 22, 2024
Last Updated: 09/26/2026